Adding Thiopurine After Loss of Response to Infliximab Versus Early Combination in Treating Crohn’s Disease: A Retrospective Study

MLA

Yuichi Matsuno, et al. “Adding Thiopurine After Loss of Response to Infliximab Versus Early Combination in Treating Crohn’s Disease: A Retrospective Study.” Digestive Diseases and Sciences, vol. 66, Sept. 2020, pp. 3124–31. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fb175b008ca548a43e143895fdac6c31&authtype=sso&custid=ns315887.

APA

Yuichi Matsuno, Tomohiko Moriyama, Takehiro Torisu, Keisuke Kawasaki, Motohiro Esaki, Takanari Kitazono, Yuta Fuyuno, Atsushi Hirano, Keizo Zeze, Shin Fujioka, & Junji Umeno. (2020). Adding Thiopurine After Loss of Response to Infliximab Versus Early Combination in Treating Crohn’s Disease: A Retrospective Study. Digestive Diseases and Sciences, 66, 3124–3131.

Chicago

Yuichi Matsuno, Tomohiko Moriyama, Takehiro Torisu, Keisuke Kawasaki, Motohiro Esaki, Takanari Kitazono, Yuta Fuyuno, et al. 2020. “Adding Thiopurine After Loss of Response to Infliximab Versus Early Combination in Treating Crohn’s Disease: A Retrospective Study.” Digestive Diseases and Sciences 66 (September): 3124–31. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fb175b008ca548a43e143895fdac6c31&authtype=sso&custid=ns315887.